
Highlights
"Diabetes Tactics" Case Studies
This month's "Diabetes Tactics" case discusses what to do when a patient is on maximal doses of metformin and a sulfonylurea and still has unsatisfactory glycemic control.
Physicians' Corner - The Ever-Expanding Universe
I've just finished reading a wonderful book titled, "A Short History of Nearly Everything." It's an engaging walk through science and theories relating to our universe, from "the very beginning" to the current time.
Use of U-500 Insulin in the Treatment of Severe Insulin Resistance
Glycemic control is essential in the management of diabetes. However, many patients with diabetes are not achieving therapeutic targets, partly because they are receiving insufficient doses of insulin. This article presents an updated algorithm for the administration and dosing of U-500 insulin based on clinical experience with severe forms of insulin resistance. Guidelines are provided for dose escalation of U-500 insulin.
This article reviews the risks associated with hyperglycemia in hospitalized patients, the biologic rationale for using insulin to prevent increases in glucose levels, and strategies for managing hyperglycemia in the hospital setting.
67th American Diabetes Association Annual Scientific Session Updates
This supplement will strive to educate physicians and diabetes educators as to the importance of avoiding hyperglycemia in hospitalized patients as well as the role of postprandial hyperglycemia in increasing the risk of cardiovascular disease.
Incorporating Postprandial and Fasting Plasma Glucose into Clinical Management Strategies
Targeting plasma glucose is a widely accepted practice in the treatment of both type 1 and type 2 diabetes mellitus (DM).
